Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01272024 · ClinicalTrials.gov registry record · Phase 3
An Intervention to Improve Outcomes in Patients With Advanced Cancer
A Phase 3 study of Cancer, sponsored by Yale University.
- Completed
- Registry status
- Phase 3
- Development phase
- 146
- Enrollment target
- 1
- Study location
NCT01272024: Completed Phase 3 study of Cancer, sponsored by Yale University.
NCT01272024 is a Phase 3 study of Cancer that has completed, run by Yale University. The registered enrollment target is 146 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01272024, a Phase 3 study of Cancer, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 146 participants
- Enrollment target
- 1
- Study location
Study Summary
1.) To integrate discharge planning into an intervention provided by advanced practice nurses (APRNs)for patients with advanced cancer, 2.) To evaluate the effects of the intervention, and 3.) To explore the reach, adoption, and implementation of the intervention to facilitate the transition of patients from surgery/biopsy/chemotherapy to medical oncology in a comprehensive cancer center.
Primary Outcome
The MUIS-C contains 23 Likert scale items with scores that range from 1= strongly disagree to 5= strongly agree.
Conditions Studied
Interventions
- BEHAVIORAL Intervention
- BEHAVIORAL Symptom Education
Study Locations (1)
Connecticut
- Yale New Haven Hospital/Smilow Cancer Hospital - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2009-09 |
| Est. Completion | 2013-08 |
| Phase | Phase 3 |
What the finished NCT01272024 record still lists
NCT01272024 is an interventional study that assigns participants to a tested intervention. The registered 146 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Intervention is the first listed.
NCT01272024 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT01272024 about?
NCT01272024 is a clinical study titled "An Intervention to Improve Outcomes in Patients With Advanced Cancer". 1.) To integrate discharge planning into an intervention provided by advanced practice nurses (APRNs)for patients with advanced cancer, 2.) To evaluate the effects of the intervention, and 3.) To explore the reach, adoption, and implementation of the intervention to facilitate the transition of pati...
What is the current status of trial NCT01272024?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 146 participants. The study started on 2009-09. Estimated completion is 2013-08.
What conditions does trial NCT01272024 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT01272024?
The interventions under investigation include: Intervention (BEHAVIORAL), Symptom Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT01272024?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01272024 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01272024's enrollment target sits among peer trials
146 272nd of 615 higher than 344 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Spiritual Care or Psychotherapy Versus Palliative Care Alone in Patients With Non-Curative Malignancies
RECRUITING · Phase 3
-
DOAC - Dosing Options in AntiCoagulation Prophylaxis
RECRUITING · Phase 3
-
Abatacept in Immune Checkpoint Inhibitor Myocarditis
RECRUITING · Phase 3
-
Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)
RECRUITING · Phase 3
-
A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients
RECRUITING · Phase 3
-
Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03490929 · 146 participants · Phase 4
CEUS for Blunt Abdominal Trauma in Children
- NCT04755062 · 146 participants · NA
A Culturally-relevant Micronutrient-dense Plant-rich (mNDPR) Dietary Intervention for Native Americans
- NCT04867954 · 146 participants
Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis
- NCT05051618 · 146 participants · NA
Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia